Merrick's Animal Health LLC, a prominent player in the veterinary pharmaceutical industry, is headquartered in the United States. Founded in 1988, the company has established itself as a trusted provider of innovative health solutions for pets and livestock, with a strong operational presence across North America. Specialising in a diverse range of products, Merrick's offers unique formulations that cater to the specific health needs of animals, including nutritional supplements and veterinary pharmaceuticals. Their commitment to quality and efficacy has positioned them as a leader in the market, recognised for their dedication to animal welfare and health advancements. With a focus on research and development, Merrick's Animal Health continues to achieve notable milestones, reinforcing its reputation as a reliable partner for veterinarians and animal owners alike.
How does Merrick's Animal Health LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Merrick's Animal Health LLC's score of 93 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Merrick's Animal Health LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Bayer Aktiengesellschaft, which means that any climate commitments or emissions data may be inherited from its parent organisation. As part of its corporate family relationship with Bayer Aktiengesellschaft, Merrick's Animal Health LLC aligns with the sustainability initiatives and targets set by Bayer. This includes commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which are aimed at reducing greenhouse gas emissions across their operations. While specific reduction targets for Merrick's Animal Health LLC are not detailed, the overarching goals from Bayer Aktiengesellschaft suggest a commitment to significant emissions reductions in line with global climate standards. This includes initiatives under the CA100 and RTZ frameworks, which further emphasise the importance of climate action within the corporate structure. In summary, while Merrick's Animal Health LLC does not provide specific emissions data or reduction targets, it is positioned within a corporate framework that prioritises sustainability and climate commitments through its relationship with Bayer Aktiengesellschaft.
Access structured emissions data, company-specific emission factors, and source documents
| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 3 | 1,215 | 0,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Merrick's Animal Health LLC's Scope 3 emissions, which decreased by 16% last year and increased significantly since 2004, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 72% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 76% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Merrick's Animal Health LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.